Single-cell analysis unravels divergent gene signatures shaping seminoma stemness and metastasis

Zhouliang Bian1,2, Biying Chen1,2, Jiahui Guo1,2

  • 1Department of Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.

Cell Death Discovery
|November 7, 2025
PubMed

Insights

This study reveals key molecular drivers of testicular cancer metastasis. Identifying specific genes and immune cells helps predict and potentially treat aggressive seminoma, improving patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Seminoma is the most common testicular cancer in young males, with metastasis significantly increasing recurrence risk.
  • Understanding the molecular mechanisms of seminoma metastasis is crucial for improving patient prognosis and quality of life.

Purpose of the Study:

  • To investigate the mechanisms driving seminoma metastasis using integrated multi-omics and cell biology approaches.
  • To identify molecular signatures associated with metastatic potential for improved risk stratification.

Main Methods:

  • Single-cell RNA sequencing and TCGA data mining to analyze tumor heterogeneity.
  • Cell biology assays (e.g., sphere formation, migration) to assess gene function.
  • Analysis of the tumor immune microenvironment, focusing on T cells.

Main Results:

  • Identified a subset of seminoma cells expressing DPPA4 and PSMA7 with high stemness and metastatic potential.
  • Demonstrated that IFNG+ T cells in the immune microenvironment promote tumor differentiation and reduce aggressiveness.
  • Developed a molecular panel for identifying high-risk metastatic seminoma.

Conclusions:

  • DPPA4 and PSMA7 are key drivers of seminoma stemness and metastasis.
  • IFN-γ secreting T cells play a crucial role in mitigating tumor aggressiveness.
  • The identified molecular signatures enable better risk stratification and personalized treatment strategies for seminoma.